Squarepoint Ops LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$137,923
+12.8%
52,844
+54.7%
0.00%
Q2 2023$122,311
-77.0%
34,165
-70.6%
0.00%
-100.0%
Q2 2022$532,000
-5.5%
116,065
+194.3%
0.00%
+200.0%
Q4 2021$563,000
+336.4%
39,433
+29.6%
0.00%0.0%
Q4 2020$129,000
+81.7%
30,427
+109.8%
0.00%0.0%
Q3 2018$71,00014,5000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders